a

jfkonecn · Jan 29, 2025 · 6b1b541 · 6b1b541
1 parent 435f42e
commit 6b1b541
Showing 1 changed file with 10 additions and 8 deletions.
diff --git a/src/main/webapp/app/pages/newsPage/NewsPageContent.tsx b/src/main/webapp/app/pages/newsPage/NewsPageContent.tsx
@@ -304,11 +304,12 @@ export const NEWS_BY_DATE: { [date: string]: NewsData } = {
   '02042025': {
     priorityNews: [
       <span>
-        Happy New Year! As of January X, 2025, 15 level 1, 12 level 2, 18 level
-        3 and 11 level 4 treatments for unique biomarker-selected indications
-        were added to OncoKB. A table summarizing these changes can be found{' '}
+        Happy New Year! As of January X, 2025, fifteen Level 1, twelve Level 2,
+        eighteen Level 3 and eleven Level 4 treatments for unique
+        biomarker-selected indications were added to OncoKB. A table summarizing
+        these changes can be found here{' '}
         <YearEndReviewPageLink year={'2024'}>here</YearEndReviewPageLink>. The
-        Precision Oncology: 2024 in review article can be found{' '}
+        “Precision Oncology: 2024 in Review” article can be found{' '}
         <Linkout
           link={
             'https://aacrjournals.org/cancerdiscovery/article/14/12/2332/750142/Precision-Oncology-2024-in-ReviewPrecision'
@@ -396,7 +397,7 @@ export const NEWS_BY_DATE: { [date: string]: NewsData } = {
                 approval="ensartinib"
                 link="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-ensartinib-alk-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer"
               />
-              <PMIDLink pmids="37276871" />
+              <PMIDLink pmids="34473194" />
             </WithSeparator>,
           ],
           [
@@ -409,7 +410,8 @@ export const NEWS_BY_DATE: { [date: string]: NewsData } = {
             </WithSeparator>,
             'Colorectal Cancer',
             <div>
-              <div>Sensitivity Adagrasib + Cetuximab (Level 1)</div>
+              <div style={{ textDecoration: 'underline' }}>Sensitivity</div>
+              <div>Adagrasib + Cetuximab (Level 1)</div>
               <br />
               <div>
                 Adagrasib + Panitumumab, Sotorasib + Cetuximab, Sotorasib +
@@ -418,9 +420,9 @@ export const NEWS_BY_DATE: { [date: string]: NewsData } = {
               <br />
               <div>Binimetinib, Cobimetinib, Trametinib (Level 4)</div>
               <br />
+              <div style={{ textDecoration: 'underline' }}>Resistance</div>
               <div>
-                Resistance Cetuximab, Panitumumab, Tucatinib + Trastuzumab
-                (Level R1)
+                Cetuximab, Panitumumab, Tucatinib + Trastuzumab (Level R1)
               </div>
             </div>,
             'Sotorasib + Panitumumab (Level 1)',